Influenza A-Induced Cardiogenic Shock Requiring Temporary ECMO Support and Urgent Heart Transplantation

Abstract

We report a case of a child with familial cardiomyopathy who contracted H1N1 influenza followed by cardiovascular collapse requiring immediate arteriovenous ECMO support. Despite the lack of experience with heart transplantation (HTx) soon after H1N1 infection, HTx was considered as an exit strategy since restoration of cardiac function was considered unlikely. In contrast to the most common indication for ECMO use in patients with H1N1 infection, early ECMO support in cases with infection-induced myocardial decompensation may be lifesaving. Additionally, this report shows that urgent heart transplantation in a patient on ECMO support can be performed safely after recent H1N1 infection and simultaneous heparin-induced thrombocytopenia, which has not been reported before. This case also indicates that H1N1 vaccination should be considered for potential transplantation candidates to prevent severe infection.

Key words

cardiomyopathy - extracorporeal membrane oxygenation, ECMO - heart failure - infection - intensive care - transplantation - heart

• References

• 1 The Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators. Extracorporeal membrane oxygenation for 2009 influenza A (H1N1) acute respiratory distress syndrome. JAMA 2009; 302: 1888-1895
• 2 Hubmayr RD, Farmer JC. Should we “rescue” patients with 2009 influenza A (H1N1) and lung injury from conventional mechanical ventilation?. Chest 2010; 137: 745-746
• 3 Mitchell MD, Mikkelsen ME, Umscheid CA , et al. A systematic review to inform institutional decisions about the use of extracorporeal membrane oxygenation during the H1N1 influenza pandemic. Crit Care Med 2010; 38: 1398-1404
• 4 Green M, Allen U. H1N1 influenza A 2009 and pediatric transplantation: lessons learned and to be learned. Pediatr Transplantation 2010; 14: 1-5
• 5 Subramanian S, Clark JD, Jeffries HE , et al. Novel pH 1N1 viral cardiomyopathy requiring veno-venous extracorporeal membrane oxygenation. Pediatr Crit Care Med 2010; 11: 714-717
• 6 Buckley E, Sidebotham D, McGeorge A , et al. Extracorporeal membrane oxygenation for cardiorespiratory failure in four patients with pandemic H1N1 2009 influenza virus and secondary bacterial infection. Br J Anaesth 2010; 104: 326-329
• 7 Campbell AL, Herold BC. Immunization of pediatric solid-organ transplantation candidates: immunizations in transplant candidates. Pediatr Transplantation 2005; 9: 652-661
• 8 Danziger-Isakov LA, Husain S, Mooney MI, Hannan MM. for the ISHLT Infectious Diseases Council. The novel 2009 H1N1 influenza virus pandemic: unique considerations for programs in cardiothoracic transplantation. J Heart Lung Transplant 2009; 28: 1341-1347
• 9 Flagg A, Danziger-Isakov L, Foster C , et al. Novel 2009 H1N1 influenza virus infection requiring extracorporeal membrane oxygenation in a pediatric heart transplant recipient. J Heart Lung Transplant 2010; 29: 582-584